{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T04:28:01Z","timestamp":1783744081298,"version":"3.55.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"24","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,4,22]],"date-time":"2016-04-22T00:00:00Z","timestamp":1461283200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.vaccine.2016.04.013","type":"journal-article","created":{"date-parts":[[2016,4,18]],"date-time":"2016-04-18T08:49:31Z","timestamp":1460969371000},"page":"2745-2749","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Immunity to hepatitis B persists in adolescents 15\u201316 years of age vaccinated in infancy with three doses of hepatitis B vaccine"],"prefix":"10.1016","volume":"34","author":[{"given":"Olivier","family":"Van Der Meeren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Behre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priya","family":"Crasta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2016.04.013_bib0125","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(15)61412-X","article-title":"Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013","author":"Schweitzer","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2016.04.013_bib0130","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1586\/erv.11.151","article-title":"Hepatitis B vaccine effectiveness in the face of global HBV genotype diversity","volume":"10","author":"Cassidy","year":"2011","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2016.04.013_bib0135","doi-asserted-by":"crossref","first-page":"6266","DOI":"10.1016\/j.vaccine.2008.09.056","article-title":"The global impact of vaccination against hepatitis B: a historical overview","volume":"26","author":"Zanetti","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.04.013_bib0140","unstructured":"World Health Organization. Expanded Programme on Immunization. Global Advisory Group. Meeting (14th: 1991: Antalya T. Expanded Programme on Immunization: report of the 14th Global Advisory Group, 14-18 October 1991), Antalya, Turkey. 1992. Available at https:\/\/extranet.who.int\/iris\/restricted\/bitstream\/10665\/61561\/1\/WHO_EPI_GEN_92.1.pdf. Accessed on 04.05.15."},{"key":"10.1016\/j.vaccine.2016.04.013_bib0145","unstructured":"World Health Organization. Hepatitis B fact sheet #204 - 2015. Available at http:\/\/www.who.int\/mediacentre\/factsheets\/fs204\/en\/. Accessed on 03.11.15."},{"key":"10.1016\/j.vaccine.2016.04.013_bib0150","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/1471-2458-8-132","article-title":"Viral hepatitis in Germany: poor vaccination coverage and little knowledge about transmission in target groups","volume":"8","author":"Schenkel","year":"2008","journal-title":"BMC Public Health"},{"key":"10.1016\/j.vaccine.2016.04.013_bib0155","doi-asserted-by":"crossref","first-page":"813","DOI":"10.4161\/hv.19898","article-title":"Long-term anti-HBs antibody persistence and immune memory in children and adolescents who received routine childhood hepatitis B vaccination","volume":"8","author":"Behre","year":"2012","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2016.04.013_bib0160","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s15010-010-0039-7","article-title":"Long-term protection against hepatitis B after newborn vaccination: 20-year follow-up","volume":"38","author":"Roznovsky","year":"2010","journal-title":"Infection"},{"key":"10.1016\/j.vaccine.2016.04.013_bib0165","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/01.inf.0000154329.00361.39","article-title":"Comparative long term immunogenicity of two recombinant hepatitis B vaccines and the effect of a booster dose given after five years in a low endemicity country","volume":"24","author":"Duval","year":"2005","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2016.04.013_bib0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-2893.2003.00400.x","article-title":"Hepatitis B vaccine - do we need boosters?","volume":"10","author":"Banatvala","year":"2003","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.vaccine.2016.04.013_bib0175","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0140-6736(99)07239-6","article-title":"Are booster immunisations needed for lifelong hepatitis B immunity? European Consensus Group on Hepatitis B Immunity","volume":"355","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2016.04.013_bib0180","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1086\/503433","article-title":"Long-term protection against carriage of hepatitis B virus after infant vaccination","volume":"193","author":"van der Sande","year":"2006","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2016.04.013_bib0185","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.vaccine.2009.10.068","article-title":"Long-term protection provided by hepatitis B vaccine and need for booster dose: a meta-analysis","volume":"28","author":"Poorolajal","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.04.013_bib0190","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.tmaid.2006.04.004","article-title":"A review of the long-term protection after hepatitis A and B vaccination","volume":"5","author":"Van Damme","year":"2007","journal-title":"Travel Med Infect Dis"},{"key":"10.1016\/j.vaccine.2016.04.013_bib0195","first-page":"1","article-title":"A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: immunization of adults","volume":"55","author":"Mast","year":"2006","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.vaccine.2016.04.013_bib0200","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1186\/1471-2334-10-357","article-title":"Five years follow-up following two or three doses of a hepatitis B vaccine in adolescents aged 11-15 years: a randomised controlled study","volume":"10","author":"Van Damme","year":"2010","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2016.04.013_bib0205","doi-asserted-by":"crossref","first-page":"592","DOI":"10.4161\/hv.9051","article-title":"Immune memory to hepatitis B virus in 4-9-year old children vaccinated in infancy with four doses of hexavalent DTPa-HBV-IPV\/Hib vaccine","volume":"5","author":"Zinke","year":"2009","journal-title":"Hum Vaccin"},{"key":"10.1016\/j.vaccine.2016.04.013_bib0210","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.vaccine.2009.10.074","article-title":"Persistence of antibodies and immune memory to hepatitis B vaccine 20 years after infant vaccination in Thailand","volume":"28","author":"Poovorawan","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.04.013_bib0215","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.4161\/hv.24844","article-title":"Long-term anti-HBs antibody persistence following infant vaccination against hepatitis B and evaluation of anamnestic response: a 20-year follow-up study in Thailand","volume":"9","author":"Poovorawan","year":"2013","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2016.04.013_bib0220","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.vaccine.2012.11.037","article-title":"Antibody persistence and the effect of a booster dose given 5, 10 or 15 years after vaccinating preadolescents with a recombinant hepatitis B vaccine","volume":"31","author":"Gilca","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.04.013_bib0225","doi-asserted-by":"crossref","first-page":"6048","DOI":"10.1016\/j.vaccine.2009.07.100","article-title":"Antibody kinetics among 8-10 years old respondents to hepatitis B vaccination in a low endemic country and the effect of a booster dose given 5 or 10 years later","volume":"27","author":"Gilca","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.04.013_bib0230","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.4161\/hv.28480","article-title":"Immune memory to hepatitis B persists in children aged 7-8 years, who were vaccinated in infancy with 4 doses of hexavalent DTPa-HBV-IPV\/Hib (Infanrix hexa) vaccine","volume":"10","author":"Van Der Meeren","year":"2014","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2016.04.013_bib0235","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.vaccine.2009.10.110","article-title":"Hepatitis B vaccines: WHO position paper - recommendations","volume":"28","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.04.013_bib0240","first-page":"255","article-title":"Hepatitis B vaccines. WHO Position paper","volume":"79","year":"2004","journal-title":"Weekly Epdemiol Rec"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16301426?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16301426?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,13]],"date-time":"2018-09-13T07:26:53Z","timestamp":1536823613000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X16301426"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":24,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["S0264410X16301426"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.04.013","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunity to hepatitis B persists in adolescents 15\u201316 years of age vaccinated in infancy with three doses of hepatitis B vaccine","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.04.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 GSK Biologicals SA. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}